President-elect Donald Trump interviewed what appear to be two unconventional candidates for FDA commissioner, but at least one other potential selection remains among those that could receive the nomination.
The transition team indicated that Trump met with Jim O'Neill, managing director of Mithril Capital Management, and Balaji Srinivasan, who is a founder of a direct-to-consumer genetic testing company, as...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?